Professor Mark W Grinstaff is the William Fairfield Warren Distinguished Professor, and Professor of Biomedical Engineering, Chemistry, Materials Science and Engineering, and Medicine at Boston University (BU). He is also the Director of BU’s Nanotechnology Innovation Center and the Director of the NIH T32 Biomaterials Program ‘Translational Research in Biomaterials’.
Mark's awards include the ACS Nobel Laureate Signature Award, NSF Career Award, Pew Scholar in the Biomedical Sciences, Camille Dreyfus Teacher-Scholar, Alfred P Sloan Research Fellowship, the Edward M Kennedy Award for Health Care Innovation, the Clemson Award for Applied Research, and the ACS Award in Applied Polymer Science. He is a Fellow of the American Institute of Medical and Biological Engineering, the American Academy of Nanomedicine, the American Institute of Chemists, the Biomedical Engineering Society, the Royal Chemical Society, the Royal Society of Medicine, the International Academy of Medical and Biological Engineering, the American Association for the Advancement of Science, and a Founding Fellow of the National Academy of Inventors.
Over the course of his tenure, Mark’s ground-breaking research has yielded more than 400 peer-reviewed publications, more than 200 patents and patent applications, and more than 325 oral presentations. His work has been cited over 40,000 times. He is an entrepreneur and co-founder, and his innovative ideas have led to several new regulatory approved products that are now the standard of care.
His current research activities involve the synthesis of new macromolecules and biomaterials, self-assembly chemistry, imaging contrast agents, drug delivery, and wound repair.